Pharmacodynamics of Insulin Preparations Administered in Different Subcutaneous Injection Sites: Are There Differences Between Healthy Subjects Versus Diabetic Patients?

Srinivas Nuggehally R.

首页> 外文期刊>Clinical drug investigation >Pharmacodynamics of Insulin Preparations Administered in Different Subcutaneous Injection Sites: Are There Differences Between Healthy Subjects Versus Diabetic Patients?

【24h】

Pharmacodynamics of Insulin Preparations Administered in Different Subcutaneous Injection Sites: Are There Differences Between Healthy Subjects Versus Diabetic Patients?

机译：在不同皮下注射部位施用胰岛素制剂的药效学：健康受试者与糖尿病患者之间有差异吗？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical drug investigation》 |2017年第9期|共4页
作者
Srinivas Nuggehally R.;
展开▼
作者单位

Zydus Res Ctr Sarkhej Bavla NH 8A Ahmadabad 382210 Gujarat India;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Pharmacodynamics of Insulin Preparations Administered in Different Subcutaneous Injection Sites: Are There Differences Between Healthy Subjects Versus Diabetic Patients? [J] . Srinivas Nuggehally R. Clinical drug investigation . 2017,第9期

机译：在不同皮下注射部位施用胰岛素制剂的药效学：健康受试者与糖尿病患者之间有差异吗？
2. Continuous Subcutaneous Insulin Infusion (CSII) of Insulin Aspart Versus Multiple Daily Injection of Insulin Aspart/Insulin Glargine in Type 1 Diabetic Patients Previously Treated With CSII. [J] . Hirsch IB, Bode BW, Garg S, Diabetes care . 2005,第3期

机译：门冬胰岛素的连续皮下胰岛素输注（CSII）与先前用CSII治疗的1型糖尿病患者每日多次注射门冬胰岛素/甘精胰岛素。
3. Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra|[reg]| [J] . R C Rosen, L E Diamond, D C Earle, International Journal of Impotence Research . 2004,第2期

机译：在健康的男性受试者和对伟哥反应不足的患者中评估皮下注射melanocortin受体激动剂PT-141的安全性，药代动力学和药效学效果
4. PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES OF INSULIN ASPART FOLLOWING SUBCUTANEOUS AND INTRAMUSCULAR INJECTION IN CATS [C] . Hannah Pipe-Martin, Jon Fletcher, Chen Gilor, Conference of the American^College^of^Veterinary^Internal^Medicine . 2016

机译：胰岛素肌肉内注射后胰岛素Aspart的药物动力学和药代动力学特性
5. Pharmacokinetic/Pharmacodynamic Analyses of Avatrombopag in Healthy Subjects and Patients with Chronic Liver Disease [D] . NOMOTO, Maiko 2019

机译：阿法曲巴帕在健康受试者和慢性肝病患者中的药代动力学/药效学分析
6. A Randomized Study of the Relative Pharmacokinetics Pharmacodynamics and Safety of Alirocumab a Fully Human Monoclonal Antibody to PCSK9 After Single Subcutaneous Administration at Three Different Injection Sites in Healthy Subjects [O] . Catherine Lunven, Tobias Paehler, Franck Poitiers, -1

机译：在健康受试者的三个不同注射部位进行单次皮下给药后对PCSK9的全人类单克隆抗体Alirocumab的相对药代动力学药效学和安全性的随机研究
7. A RANDOMIZED STUDY OF THE RELATIVE BIOAVAILABILITY, PHARMACODYNAMICS, AND SAFETY OF ALIROCUMAB, A FULLY HUMAN MONOCLONAL ANTIBODY TO PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, AFTER SINGLE SUBCUTANEOUS ADMINISTRATION AT THREE DIFFERENT INJECTION SITES IN HEALTHY SUBJECTS [O] . Lunven Catherine, Paehler Tobias, Lewanczyk Pascale, 2014

机译：多次连续三个剂量的单次连续给药后，对蛋白质的完全人类单克隆抗体阿洛洛单抗的相对生物利用度，药动学和安全性的随机研究。

Pharmacodynamics of Insulin Preparations Administered in Different Subcutaneous Injection Sites: Are There Differences Between Healthy Subjects Versus Diabetic Patients?

著录项

相似文献

相关主题

期刊订阅